The first half of 2026 was marked by significant momentum for the Life Science industry across the DACH region. European regulatory initiatives, the increasing adoption of artificial intelligence, and ongoing geopolitical and economic uncertainty have had a lasting impact on the strategic direction of many companies. At the same time, topics such as digital clinical trials, Real-World Evidence, and resilient supply chains continue to gain importance.
Despite a challenging market environment, the industry’s capacity for innovation remains strong. Scientific breakthroughs, new therapeutic approaches, and ongoing technological advancements continue to drive progress. At the same time, the job market remains stable but increasingly selective, with particularly high demand for highly qualified professionals in scientific, regulatory, quality, and data-driven roles.
In our Aristo Half Year Report 2026, we analyze:
- The key topics that shaped the Life Science industry in the first half of 2026
- How the Life Science job market developed across Germany, Austria, and Switzerland
- Which roles and professional profiles are currently most in demand
- What these developments mean for your recruiting and talent strategy
Download the report now and gain valuable insights into the latest developments in the Life Science industry, along with practical guidance for your recruiting and talent strategy in the second half of 2026.
